Sign up to save your podcasts
Or
Share S1 E3: ADHD Across Life Transitions: Practical Approaches for Primary Care w/ Dr. Elisabeth Baerg Hall
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
S1 E3: ADHD Across Life Transitions: Practical Approaches for Primary Care w/ Dr. Elisabeth Baerg Hall
Guest: Dr. Elizabeth Baerg Hall
Host: Dr. Chris Morrow
Producer: Craig Ferguson
Music: "Stand With Me" by Adrian Walther licensed via SoundStripe
Episode Timestamps
• [00:00] - Introduction and episode overview
• [02:03] - Life transitions and when ADHD becomes visible in adults
• [04:14] - How ADHD can be masked by structure and support systems
• [05:21] - Red flags for ADHD in primary care settings
• [08:54] - Who can diagnose ADHD and what tools are available
• [12:05] - The importance of impairment in diagnosis and avoiding overdiagnosis
• [16:36] - Common comorbidities: Anxiety, depression, and bipolar disorder
• [19:39] - ADHD and substance use disorder
• [21:26] - Barriers to diagnosis and treatment: Stigma and misconceptions about stimulants
• [24:07] - Inequities in access to care, including Indigenous patients
• [26:26] - Challenges for rural patients and older adults with ADHD
• [29:00] - Resources and support in BC: CADRA, Shared Care, and Skills for Success
• [30:56] - ADHD pathways and UBC CPD educational opportunities
• [32:59] - Closing remarks and conference information
• [33:52] - Knowledge nugget: The history of psychostimulants
Studies & Research Mentioned
• CADDRA – Canadian ADHD Resource Alliance. Canadian ADHD Practice Guidelines, 4.1 Edition. Toronto, ON: CADDRA; 2020. Accessed January 13, 2026. https://adhdlearn.caddra.ca/wp-content/uploads/2022/08/Canadian-ADHD-Practice-Guidelines-4.1-January-6-2021.pdf
• Centers for Disease Control and Prevention. Diagnosing ADHD. Updated 2024. Accessed January 13, 2026. https://www.cdc.gov/adhd/diagnosis/index.html
• The MTA Cooperative Group: A 14-Month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder (ADHD) . Arch Gen Psychiatry 1999;56:1073-1086.
• The MTA Cooperative Group: Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder (ADHD). Arch Gen Psychiatry 1999;56:1088-1096.
• Molina BSG, Kipp HL, Joseph HM, et al. Stimulant Diversion Risk Among College Students Treated for ADHD: Primary Care Provider Prevention Training. Acad Pediatr. 2020;20(1):119-127. doi:10.1016/j.acap.2019.06.002
• National Institute of Mental Health. The Multimodal Treatment of Attention Deficit Hyperactivity Disorder Study (MTA): Questions and Answers. Revised November 2009. National Institute of Mental Health website. Accessed January 13, 2026. https://www.nimh.nih.gov/funding/clinical-research/practical/mta/the-multimodal-treatment-of-attention-deficit-hyperactivity-disorder-study-mtaquestions-and-answers
• Ramtekkar UP, Reiersen AM, Todorov AA, Todd RD. Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry. 2010;49(3):217-28.e283.
(C) 2025 UBC Medicine Learning Network
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
View all episodes
By UBC CPDGuest: Dr. Elizabeth Baerg Hall
Host: Dr. Chris Morrow
Producer: Craig Ferguson
Music: "Stand With Me" by Adrian Walther licensed via SoundStripe
Episode Timestamps
• [00:00] - Introduction and episode overview
• [02:03] - Life transitions and when ADHD becomes visible in adults
• [04:14] - How ADHD can be masked by structure and support systems
• [05:21] - Red flags for ADHD in primary care settings
• [08:54] - Who can diagnose ADHD and what tools are available
• [12:05] - The importance of impairment in diagnosis and avoiding overdiagnosis
• [16:36] - Common comorbidities: Anxiety, depression, and bipolar disorder
• [19:39] - ADHD and substance use disorder
• [21:26] - Barriers to diagnosis and treatment: Stigma and misconceptions about stimulants
• [24:07] - Inequities in access to care, including Indigenous patients
• [26:26] - Challenges for rural patients and older adults with ADHD
• [29:00] - Resources and support in BC: CADRA, Shared Care, and Skills for Success
• [30:56] - ADHD pathways and UBC CPD educational opportunities
• [32:59] - Closing remarks and conference information
• [33:52] - Knowledge nugget: The history of psychostimulants
Studies & Research Mentioned
• CADDRA – Canadian ADHD Resource Alliance. Canadian ADHD Practice Guidelines, 4.1 Edition. Toronto, ON: CADDRA; 2020. Accessed January 13, 2026. https://adhdlearn.caddra.ca/wp-content/uploads/2022/08/Canadian-ADHD-Practice-Guidelines-4.1-January-6-2021.pdf
• Centers for Disease Control and Prevention. Diagnosing ADHD. Updated 2024. Accessed January 13, 2026. https://www.cdc.gov/adhd/diagnosis/index.html
• The MTA Cooperative Group: A 14-Month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder (ADHD) . Arch Gen Psychiatry 1999;56:1073-1086.
• The MTA Cooperative Group: Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder (ADHD). Arch Gen Psychiatry 1999;56:1088-1096.
• Molina BSG, Kipp HL, Joseph HM, et al. Stimulant Diversion Risk Among College Students Treated for ADHD: Primary Care Provider Prevention Training. Acad Pediatr. 2020;20(1):119-127. doi:10.1016/j.acap.2019.06.002
• National Institute of Mental Health. The Multimodal Treatment of Attention Deficit Hyperactivity Disorder Study (MTA): Questions and Answers. Revised November 2009. National Institute of Mental Health website. Accessed January 13, 2026. https://www.nimh.nih.gov/funding/clinical-research/practical/mta/the-multimodal-treatment-of-attention-deficit-hyperactivity-disorder-study-mtaquestions-and-answers
• Ramtekkar UP, Reiersen AM, Todorov AA, Todd RD. Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J Am Acad Child Adolesc Psychiatry. 2010;49(3):217-28.e283.
(C) 2025 UBC Medicine Learning Network
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.